MGH researchers gain insight into mechanism of promising therapy to reduce liver fat and prevent fibrosis progression in common form of liver disease
A team led by researchers at Massachusetts General Hospital has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease.